It seems that there is no content provided for summarization. Please provide the text you'd like summarized, and I'll be happy to help!
GSK has been in the news recently: Frontier Biotechnologies Inc. licensed two siRNA products to GSK for an upfront payment of $40 million, with additional potential milestones totaling $963 million. This agreement aims to enhance GSK's global development strategy.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.